Table 3 Overview of the treatment efficiency of specific osteoporosis treatment for post-menopausal women [4]
Compound | Fewer vertebral body fractures | Fewer peripheral fractures | Fewer proximal femur fractures |
|---|---|---|---|
Alendronate | A | A | A |
Denosumab | A | A | A |
Ibandronate | A | B | – |
Risedronate | A | A | A |
Zoledronate | A | A | A |
Teriparatide | A | B | – |